RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$926M
AUM Growth
+$212M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
99
New
Increased
Reduced
Closed

Top Buys

1
+$17.7M
2
+$9.4M
3
+$8.18M
4
XLRN
Acceleron Pharma
XLRN
+$8.1M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.8M

Top Sells

1
+$13.9M
2
+$9.07M
3
+$8.61M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$6.71M
5
NKTR icon
Nektar Therapeutics
NKTR
+$6.6M

Sector Composition

1 Healthcare 94.86%
2 Communication Services 1.03%
3 Energy 0.07%
4 Technology 0.06%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$41.7M 4.5%
750,000
-250,000
2
$39.9M 4.31%
137,500
+22,500
3
$31M 3.35%
105,000
+25,000
4
$29.5M 3.18%
300,000
-30,000
5
$23.4M 2.53%
190,000
+5,155
6
$22.3M 2.41%
380,000
+30,000
7
$22.2M 2.4%
375,000
+15,000
8
$21.8M 2.36%
425,000
-167,798
9
$21.3M 2.3%
55,000
+10,000
10
$21.3M 2.3%
190,000
+30,000
11
$20.6M 2.23%
110,000
+5,000
12
$18.8M 2.04%
675,000
-325,000
13
$18.3M 1.98%
52,667
-19,000
14
$17.7M 1.91%
+230,000
15
$17.2M 1.86%
105,000
+5,000
16
$17.1M 1.85%
65,000
17
$16.9M 1.83%
185,000
+15,000
18
$16.5M 1.78%
470,000
+5,000
19
$16.4M 1.77%
68,000
-20,000
20
$16.3M 1.76%
460,000
-130,000
21
$15.5M 1.67%
160,000
-20,000
22
$15.4M 1.66%
210,000
+70,000
23
$15.1M 1.63%
137,032
+17,032
24
$15M 1.62%
185,000
+10,000
25
$14.9M 1.61%
234,378
+59,378
1
2 3 4